Tag
Sriram Natarajan
3 articles
Molbio Diagnostics Q1 FY27 Revenue ₹408 Crore
Molbio reported Q1 FY27 consolidated revenue of ₹408 crore with an EBITDA margin of 25% and PAT of ₹52.7 crore.
Management provided FY27 growth guidance of ~25% revenue growth and 24-25% EBITDA margin
Molbio Diagnostics Q1 PAT at ₹52.74 Cr
Molbio Diagnostics reported Q1 FY27 unaudited results with Total Income of ₹411.48 Cr, a significant increase from ₹100.47 Cr in Q1 FY26.
EBITDA improved to ₹103.68 Cr profit from a ₹14.50 Cr loss in
Molbio Diagnostics Q1 FY27 Net Profit at ₹527 Million
Board approved un-audited standalone and consolidated financial results for Q1 FY27, with standalone net profit of ₹566.27 million and consolidated net profit of ₹527.44 million.
Company completed its